Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Statera Biopharma, Inc. (CBLI)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-22Sep-30-21Jun-30-21Dec-31-20Sep-30-20Jun-30-20Mar-31-20Dec-31-19
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income  -3.3-12.7-0.7-0.7-0.7-0.4-0.6-0.7
Depreciation and amortization   [+] 0.0 0.00.00.00.00.0
Stock-based compensation   5.0  0.0   
Change in working capital   [+] -2.4 0.10.00.00.01.1
Other operating activities  0.0-9.50.0-0.20.1-0.10.2-0.7
Cash from operations  -3.4-19.6-0.7-0.8-0.7-0.5-0.4-0.4
   
Capital expenditures   [+]0.0-0.10.00.00.00.00.00.0
Sales of short-term investments   -0.3 0.30.00.4 0.4
Other cash from investing   13.6 -0.30.0-0.4 -0.4
Cash from investing  0.013.20.00.00.00.00.00.0
   
Repurchase of common stock, net   -7.0 2.8 2.8  
Financing costs   -0.3      
Other cash from financing   14.9 -2.8  0.4 
Cash from financing  0.08.20.00.00.02.80.40.0
   
Free cash flow  -3.4-19.7-0.7-0.8-0.7-0.5-0.4-0.4
        Per share (diluted)  ($0.07)($0.73)($0.04)($0.06)($0.05)($0.04)($0.04)($0.03)
   
Cash paid for interest   0.3      

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy